Pharming Group Nv Stock Investor Sentiment

PHGUF Stock  USD 0.90  0.11  13.92%   
Roughly 55% of Pharming Group's stockholders are presently thinking to get in. The analysis of overall sentiment of trading Pharming Group NV pink sheet suggests that some investors are interested at this time. The current market sentiment, together with Pharming Group's historical and current headlines, can help investors time the market. In addition, many technical investors use Pharming Group NV stock news signals to limit their universe of possible portfolio assets.
Pharming Group pink sheet news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Pharming daily returns and investor perception about the current price of Pharming Group NV as well as its diversification or hedging effects on your existing portfolios.
  
3 days ago at news.google.com         
Pharming Group Reports Strong 2024 Revenue Growth - TipRanks
Google News at Macroaxis
over a week ago at news.google.com         
Pharming Group Appoints New CEO to Strengthen Market Position - TipRanks
Google News at Macroaxis
over two weeks ago at news.google.com         
Pharming Group Trading 6.2 percent Higher - Should You Buy - MarketBeat
Google News at Macroaxis
over a month ago at news.google.com         
Trading With Integrated Risk Controls - Stock Traders Daily
Google News at Macroaxis
over a month ago at news.google.com         
Pharming Group Sees Large Volume Increase - Heres Why - MarketBeat
Google News at Macroaxis
over a month ago at news.google.com         
Pharming Group Shares Gap Up - Time to Buy - MarketBeat
Google News at Macroaxis
over a month ago at news.google.com         
Pharming Group Sees Unusually-High Trading Volume - Still a Buy - MarketBeat
Google News at Macroaxis
over a month ago at news.google.com         
Pharming Group Sets EGM to Appoint Fabrice Chouraqui as New CEO in Leadership Transition - StockTita...
Google News at Macroaxis
over a month ago at news.google.com         
Pharming Group Shares Gap Up - Heres Why - MarketBeat
Google News at Macroaxis
over two months ago at news.google.com         
Pharming Group Shares Gap Down - Heres What Happened - MarketBeat
Google News at Macroaxis
over two months ago at news.google.com         
3 Promising Penny Stocks With At Least US80M Market Cap - Simply Wall St
Google News at Macroaxis
over two months ago at news.google.com         
Pharming Group Shares Gap Up - Should You Buy - MarketBeat
Google News at Macroaxis
over two months ago at news.google.com         
Pharming Group Shares Gap Down - Heres What Happened - MarketBeat
Google News at Macroaxis
over three months ago at news.google.com         
Pharming Group Launches 66M Bid for Abliva, Eyes Rare Disease Drug Market with KL1333 Asset - StockT...
Google News at Macroaxis
over three months ago at news.google.com         
Pharming Group Given Buy Rating at HC Wainwright - MarketBeat
Google News at Macroaxis
Far too much social signal, news, headlines, and media speculation about Pharming Group that are available to investors today. That information is available publicly through Pharming media outlets and privately through word of mouth or via Pharming internal channels. However, regardless of the origin, that massive amount of Pharming data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Pharming Group news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Pharming Group relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Pharming Group's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Pharming Group alpha.

Pharming Group Performance against Dow Jones

 Price Growth (%)  
       Timeline  

Complementary Tools for Pharming Pink Sheet analysis

When running Pharming Group's price analysis, check to measure Pharming Group's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pharming Group is operating at the current time. Most of Pharming Group's value examination focuses on studying past and present price action to predict the probability of Pharming Group's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pharming Group's price. Additionally, you may evaluate how the addition of Pharming Group to your portfolios can decrease your overall portfolio volatility.
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
CEOs Directory
Screen CEOs from public companies around the world
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance